Everything Matters

Our People

 



  RSS

Kimberly K. Egan  


Partner
Co-Chair, Health Care Sector

kimberly.egan@dlapiper.com

  vCard     Print version (PDF)

500 Eighth Street, NW
Washington, DC 20004
United States
T: +1 202 799 4506   F: +1 202 799 5506

Kim Egan is the co-chair of the firm's US Health Care sector, which is ranked by Legal 500 as a leading FDA and health care practice. She focuses on FDA advice and counseling, pharmaceutical and other complex litigation, and Consumer Product Safety Commission work. Ms. Egan is also Co-Chair of the Clinical Trials Working Group in the firm's Life Sciences Sector.

Ms. Egan appears on the Legal 500 list of Recommended Health Care and Life Sciences Lawyers. She has been listed in the International Who's Who of Life Sciences Lawyers and the International Who's Who of Business Lawyers since 2009. She sits on the Legal Affairs and Audit Committee of the Children's National Medical Center in Washington, DC, and is on the advisory board of Life Sciences Law & Industry Report, a publication for lawyers, business executives, directors of research and regulatory specialists practicing in health care-related life sciences fields.

Ms. Egan writes frequently on food and life sciences issues as well as the legal profession. She is a contributor to and editor of DLA Piper's Health Care blog, Health Care Law Matters, available at www.healthcarelawmatters.com. She blogs about food regulatory issues specifically on "Food Stuff." Her 2011 National Law Journal article "What Associates Didn't Learn in Law School" was for a time the most read article on Law.com.

Ms. Egan is chairman of the board of Friends Together for Sudan, an organization dedicated to educating women and girls in Southern Sudan. She serves on the board of directors for Safe Kids Worldwide, which works to reduce preventable childhood injuries around the world. She also sits on the board of the Centre for Development and Population Activities (CEDPA), which works to improve the lives of women and girls in the developing world.

Admissions

  • District of Columbia
  • New York
  • United States District Court for the District of Columbia
  • United States District Court for the District of Maryland
  • United States District Court for the Southern District of New York
  • United States District Court for the Eastern District of New York
  • United States Court of Appeals for the District of Columbia Circuit

Publications

  • Co-Author, Getting the Deal Through: Life Sciences (US Chapter) February 2011
  • "What Associates Didn't Learn in Law School," The National Law Journal, February 28, 2011
  • Co-Author, Getting the Deal Through: Life Sciences (US Chapter), February 2010
  • Quoted in "FDA's New Enforcement Initiative for 2010," Financier Worldwide, January 2010
  • Quoted in "A Glimmer of Hope for Retrospective Analyses of Data," Good Clinical Practice Journal, June 2009
  • "Mitigating Corporate Corruption in the Healthcare Industry," Financier Worldwide, July 2009)
  • Co-author, "Made in China: Five Opportunities Created by the Recent Recalls," For the Defense, International Law section, March 2009
  • Co-author, "The China Syndrome: Five Lessons to Learn from Recent Scandals Involving Chinese Products," richmondmagazineonline.com. December/January 2009
  • Co-author, "Genetically Modified Foods Raise New Legal Issues," The National Law Journal, June 25, 2001

Seminars

  • Panelist, CBI's "Clinical R&D Compliance Forum," Philadelphia (June 28-29, 2010)
  • Presenter, "Supply Chain Challenges in the New Regulatory Environment," Association of Corporate Counsel, San Francisco Bay Area Chapter (April 27 and 29, 2010)
  • Presenter, "Global Supply Chains Issues in the Global Era: Prevention, Protection and Compliance," Association of Corporate Counsel, Baltimore Chapter luncheon, Baltimore (January 27, 2010)
  • Presenter, "Trends and Developments in Consumer Product Enforcement and Litigation," Hong Kong Productivity Council and Federation of Hong Kong Industries, Hong Kong (January 22, 2010)
  • Panelist, "Global Supply Chains in the Global Era: Prevention, Protection and Compliance," Association for Corporate Counsel Chicago Chapter luncheon, Chicago (July 22, 2009)
  • Co-leader, "The Impact on Emerging Growth Companies of Issues Affecting FDA Regulations and Compliance," Hot Topics in Regulatory Affairs Workshop, co-sponsored by DLA Piper and CONNECT, San Diego, CA (June 23, 2009)
  • Speaker, "Shoring up Weak Links in the Pharmaceutical Supply Chain," webinar, Marsh Risk Consulting and Pharmaceutical Manufacturing magazine (October 28, 2008)
  • Presenter, DRI Webinar, "Drug Development and Approval: A Partnership Between FDA and Industry – Crossing Paths with FDA" (July 18, 2006)

Civic and Charitable

  • Legal Affairs and Audit Committee, Children's National Medical Center
  • Chairman of the Board, Friends Together for Sudan
  • Board Member, Safe Kids Worldwide
  • Board Member, Centre for Development and Population Activities (CEDPA)
  • Advisory Board Member, Life Sciences Law and Industry Reporter
  • 2011 Host Committee, Heroes Curing Childhood Cancer Gala, Children's National Medical Center


EDUCATION

  • J.D., Duke University School of Law 1997
  • B.A., English/Women's Studies, Columbia University 1992

Contact Us Corporate Responsibility RSS Site Map Accessible Site Legal Notices Privacy Policy Cookie Policy Attorney Advertising 中文版
© 2012 DLA Piper. DLA Piper is a global law firm operating through various separate and distinct legal entities. For further information about these entities and DLA Piper's structure, please refer to the Legal Notices page of this website. All rights reserved.
  Click to follow us on Twitter Click to follow us on LinkedIn Click to follow us on Facebook Click to follow us on YouTube Click to follow us on Flickr